Hospital
Johns Hopkins All Children's Hospital, INC
Johns Hopkins All Children's Hospital, INC was paid $152.82M by Medicaid between Jan 2018 and Dec 2024, across 540 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 18% of everything it billed.
33Billing provider infoJOHNS HOPKINS ALL CHILDREN'S HOSPITAL, INC
ST PETERSBURG, FL 33701
ST PETERSBURG, FL 33701
33aNPI1427114099assigned 12/28/2006
33bProvider typeChildren's Hospital
28Total paid$152.82M
24GClaims1,429,913
24DCodes billed540
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Children's Hospital providers in Florida
Rank by total paid#1 of 6
Median peer was paid$668K
This provider vs. median229×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,471 | $1.05M | |
| 2019 | 320,735 | $33.74M | |
| 2020 | 271,621 | $27.25M | |
| 2021 | 383,405 | $35.13M | |
| 2022 | 242,972 | $24.44M | |
| 2023 | 129,928 | $20.56M | |
| 2024incomplete | 58,781 | $10.66M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 18% | 105,589 | 29,058 | $27.15M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 85,077 | 79,838 | $19.00M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9.1% | 81,563 | 23,579 | $13.90M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.2% | 37,997 | 35,895 | $11.00M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 5.5% | 52,768 | 16,408 | $8.43M |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 3.1% | 6,617 | 6,278 | $4.79M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 8,230 | 7,717 | $4.57M |
| 80053 | Comprehensive metabolic panel | 2.8% | 44,492 | 37,197 | $4.35M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.2% | 16,150 | 15,278 | $3.30M |
| G0378 | Hospital observation service, per hour | 1.4% | 11,896 | 5,436 | $2.14M |
| 92523 | 1.4% | 8,450 | 8,176 | $2.11M | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.2% | 7,565 | 7,011 | $1.88M |
528 more codes
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.1% | 1,734 | $1.74M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 17,210 | $1.72M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 1.0% | 801 | $1.60M |
| 94375 | 1.0% | 11,372 | $1.55M | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.0% | 3,521 | $1.54M |
| T1017 | Case management, billed per 15 minutes | <1% | 59,906 | $1.53M |
| 92526 | <1% | 11,875 | $1.49M | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 4,796 | $1.16M |
| 95782 | <1% | 973 | $966K | |
| 54161 | <1% | 1,060 | $721K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,836 | $708K |
| 97162 | <1% | 2,107 | $690K | |
| 82657 | <1% | 3,014 | $665K | |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | <1% | 631 | $662K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,940 | $647K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,224 | $629K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 11,198 | $624K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 3,659 | $621K |
| 92610 | <1% | 2,778 | $619K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 2,514 | $603K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24,246 | $599K |
| 76770 | <1% | 3,481 | $590K | |
| 97161 | <1% | 2,507 | $575K | |
| 92579 | <1% | 3,752 | $574K | |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 823 | $559K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,789 | $553K |
| 93304 | <1% | 818 | $530K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,442 | $519K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 4,692 | $518K |
| 01922 | <1% | 1,337 | $514K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,912 | $494K |
| T1024 | Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter | <1% | 3,968 | $487K |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 3,598 | $452K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,303 | $451K |
| 97166 | <1% | 1,522 | $430K | |
| 81025 | <1% | 8,444 | $428K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 565 | $424K |
| 76825 | <1% | 1,196 | $415K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 1,130 | $411K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 47,860 | $408K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,960 | $398K |
| 74230 | <1% | 1,710 | $381K | |
| 97165 | <1% | 1,363 | $377K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,230 | $366K |
| 93308 | <1% | 774 | $353K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 1,031 | $345K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 8,692 | $334K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 5,684 | $329K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,741 | $318K |
| 88304 | <1% | 5,576 | $313K | |
| 95819 | <1% | 893 | $298K | |
| 97755 | <1% | 1,306 | $295K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,543 | $290K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 11,777 | $289K |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 561 | $281K |
| 87081 | <1% | 5,266 | $278K | |
| 86850 | <1% | 2,211 | $267K | |
| 92588 | <1% | 1,930 | $259K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 10,589 | $258K |
| 87070 | <1% | 5,915 | $250K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,892 | $250K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,555 | $239K |
| 93975 | <1% | 1,274 | $226K | |
| 97164 | <1% | 853 | $220K | |
| 93325 | <1% | 9,635 | $199K | |
| 92557 | <1% | 892 | $193K | |
| 81229 | <1% | 380 | $192K | |
| 70360 | <1% | 2,328 | $189K | |
| 97802 | <1% | 824 | $186K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 458 | $185K |
| 82784 | <1% | 5,276 | $181K | |
| 87507 | <1% | 673 | $180K | |
| 74018 | <1% | 3,616 | $180K | |
| 80195 | <1% | 1,125 | $174K | |
| 92552 | <1% | 1,564 | $173K | |
| 92555 | <1% | 5,690 | $172K | |
| 97542 | <1% | 1,323 | $170K | |
| 92524 | <1% | 572 | $168K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 6,520 | $162K |
| 97168 | <1% | 924 | $162K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 1,491 | $156K |
| 95816 | <1% | 400 | $156K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 954 | $151K |
| 76536 | <1% | 1,093 | $151K | |
| 92586 | <1% | 1,024 | $148K | |
| 95811 | <1% | 162 | $148K | |
| 82785 | <1% | 3,432 | $148K | |
| 82962 | <1% | 3,677 | $143K | |
| 92651 | <1% | 1,034 | $140K | |
| 82728 | <1% | 5,312 | $139K | |
| 76377 | <1% | 1,976 | $137K | |
| 81001 | <1% | 20,951 | $136K | |
| 44970 | <1% | 69 | $133K | |
| 92593 | <1% | 2,405 | $132K | |
| 42830 | <1% | 370 | $130K | |
| 92582 | <1% | 974 | $130K | |
| 77072 | <1% | 1,536 | $128K | |
| 86003 | <1% | 3,507 | $128K | |
| 89051 | <1% | 764 | $125K | |
| 97803 | <1% | 538 | $122K | |
| 88300 | <1% | 2,465 | $121K | |
| 76885 | <1% | 598 | $119K | |
| 85027 | <1% | 11,013 | $117K | |
| 73090 | <1% | 1,863 | $117K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 625 | $114K |
| 74019 | <1% | 5,224 | $114K | |
| J2704 | Injection, propofol, 10 mg | <1% | 20,030 | $114K |
| 82565 | <1% | 1,170 | $110K | |
| 92630 | <1% | 2,015 | $108K | |
| 95715 | <1% | 104 | $103K | |
| 36430 | <1% | 702 | $94K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 279 | $93K |
| 96415 | <1% | 1,142 | $92K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 924 | $88K |
| 82746 | <1% | 1,208 | $83K | |
| 73610 | <1% | 1,750 | $82K | |
| 85007 | <1% | 10,475 | $79K | |
| 73630 | <1% | 1,893 | $77K | |
| 70486 | <1% | 649 | $76K | |
| 95714 | <1% | 339 | $76K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 177 | $76K |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 15,760 | $75K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,216 | $74K |
| 92567 | <1% | 8,046 | $71K | |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | <1% | 31 | $70K |
| 73070 | <1% | 1,042 | $69K | |
| 73140 | <1% | 1,090 | $69K | |
| 92620 | <1% | 235 | $68K | |
| V5264 | Ear mold/insert, not disposable, any type | <1% | 737 | $68K |
| 80069 | <1% | 1,512 | $67K | |
| 70250 | <1% | 660 | $65K | |
| 82272 | <1% | 1,321 | $65K | |
| 74240 | <1% | 365 | $63K | |
| 67311 | <1% | 55 | $61K | |
| 87631 | <1% | 3,217 | $60K | |
| 92553 | <1% | 394 | $59K | |
| 86140 | <1% | 10,879 | $59K | |
| 84439 | <1% | 9,799 | $58K | |
| 73560 | <1% | 1,650 | $58K | |
| 73130 | <1% | 1,211 | $57K | |
| 86923 | <1% | 735 | $56K | |
| 87077 | <1% | 4,772 | $54K | |
| 96409 | <1% | 823 | $54K | |
| 0001U | <1% | 118 | $54K | |
| 92585 | <1% | 446 | $53K | |
| 92592 | <1% | 1,012 | $52K | |
| 87420 | <1% | 523 | $51K | |
| 80061 | Lipid panel | <1% | 4,155 | $51K |
| 73590 | <1% | 1,239 | $47K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 11,264 | $47K |
| 80306 | <1% | 1,713 | $47K | |
| 87186 | <1% | 3,575 | $46K | |
| 14040 | <1% | 77 | $45K | |
| 82607 | <1% | 1,189 | $45K | |
| 82805 | <1% | 1,555 | $45K | |
| J1459 | Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg | <1% | 119 | $45K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 11,252 | $44K |
| 87799 | <1% | 2,577 | $43K | |
| 12011 | <1% | 960 | $43K | |
| 86317 | <1% | 1,433 | $42K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 277 | $42K |
| 83520 | <1% | 800 | $42K | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 1,204 | $40K |
| 96376 | <1% | 178 | $40K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 339 | $40K |
| 76870 | <1% | 298 | $40K | |
| 72082 | <1% | 439 | $40K | |
| 92652 | <1% | 485 | $39K | |
| 72141 | <1% | 520 | $39K | |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | <1% | 346 | $39K |
| 80076 | <1% | 1,231 | $39K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 629 | $38K |
| 83993 | <1% | 833 | $38K | |
| 80074 | <1% | 360 | $37K | |
| 93226 | <1% | 869 | $37K | |
| 85046 | <1% | 3,022 | $37K | |
| 96450 | <1% | 261 | $37K | |
| 82085 | <1% | 462 | $37K | |
| 74455 | <1% | 191 | $35K | |
| 87486 | <1% | 1,988 | $35K | |
| 72146 | <1% | 279 | $34K | |
| 95951 | <1% | 302 | $34K | |
| 72170 | <1% | 695 | $33K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,266 | $32K |
| 00120 | <1% | 155 | $31K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 32 | $30K |
| 83880 | <1% | 2,242 | $30K | |
| 92587 | <1% | 2,201 | $30K | |
| 73521 | <1% | 331 | $29K | |
| 82043 | <1% | 667 | $29K | |
| 95700 | <1% | 646 | $29K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 525 | $29K |
| 83498 | <1% | 631 | $29K | |
| 00920 | <1% | 566 | $27K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 6,439 | $27K |
| 73552 | <1% | 562 | $26K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,306 | $26K |
| 73030 | <1% | 330 | $26K | |
| C1769 | Guide wire | <1% | 505 | $26K |
| 82948 | <1% | 787 | $24K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 84 | $24K |
| 72040 | <1% | 477 | $24K | |
| 85652 | <1% | 9,286 | $23K | |
| J3490 | Unclassified drugs | <1% | 10,150 | $23K |
| 92550 | <1% | 937 | $23K | |
| 82247 | <1% | 767 | $23K | |
| 84510 | <1% | 580 | $23K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 2,315 | $22K |
| 73110 | <1% | 482 | $22K | |
| 87045 | <1% | 919 | $22K | |
| 93320 | <1% | 6,521 | $22K | |
| 93225 | <1% | 1,166 | $21K | |
| 93242 | <1% | 769 | $20K | |
| 87400 | <1% | 321 | $20K | |
| 87046 | <1% | 919 | $20K | |
| 86235 | <1% | 468 | $20K | |
| 83516 | <1% | 1,121 | $20K | |
| 76882 | <1% | 322 | $19K | |
| V5010 | Assessment for hearing aid | <1% | 500 | $16K |
| 76000 | <1% | 585 | $16K | |
| 80329 | <1% | 265 | $16K | |
| 00300 | <1% | 223 | $15K | |
| 82330 | <1% | 1,963 | $15K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 2,314 | $15K |
| 83970 | <1% | 955 | $14K | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 9,298 | $14K |
| 12001 | <1% | 439 | $13K | |
| T2101 | Human breast milk processing, storage and distribution only | <1% | 13 | $13K |
| 93976 | <1% | 863 | $13K | |
| J9370 | Vincristine sulfate, 1 mg | <1% | 1,366 | $13K |
| 83021 | <1% | 933 | $13K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 8,897 | $13K |
| 83020 | <1% | 1,995 | $12K | |
| 94060 | <1% | 73 | $12K | |
| 82570 | <1% | 2,516 | $11K | |
| 94799 | <1% | 750 | $11K | |
| 84146 | <1% | 497 | $11K | |
| 84446 | <1% | 165 | $11K | |
| 82550 | <1% | 1,957 | $11K | |
| 86355 | <1% | 1,368 | $11K | |
| 85610 | <1% | 3,672 | $11K | |
| 76881 | <1% | 119 | $10K | |
| 84702 | <1% | 610 | $10K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 4,096 | $10K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,054 | $10K |
| 88312 | <1% | 1,082 | $10K | |
| 84484 | <1% | 667 | $10K | |
| 82397 | <1% | 916 | $10K | |
| 83690 | <1% | 3,713 | $10K | |
| 83615 | <1% | 1,980 | $9K | |
| 84466 | <1% | 3,226 | $9K | |
| 87040 | <1% | 4,472 | $9K | |
| 00812 | <1% | 118 | $9K | |
| 83540 | <1% | 3,324 | $9K | |
| 54640 | <1% | 30 | $8K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 3,720 | $8K |
| 80197 | <1% | 2,658 | $8K | |
| 84403 | <1% | 1,302 | $8K | |
| 94770 | <1% | 28 | $8K | |
| 83735 | <1% | 6,618 | $8K | |
| 86902 | <1% | 28 | $8K | |
| 84703 | <1% | 874 | $8K | |
| 70480 | <1% | 44 | $8K | |
| 94762 | <1% | 757 | $8K | |
| 86592 | <1% | 710 | $8K | |
| 00813 | <1% | 395 | $8K | |
| 72100 | <1% | 275 | $8K | |
| 82670 | <1% | 626 | $7K | |
| 81408 | <1% | 19 | $7K | |
| 93017 | <1% | 31 | $7K | |
| 70543 | <1% | 40 | $7K | |
| 70210 | <1% | 95 | $7K | |
| L4350 | Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf | <1% | 75 | $7K |
| 82140 | <1% | 265 | $7K | |
| 80349 | <1% | 266 | $7K | |
| 0279U | <1% | 53 | $7K | |
| 92604 | <1% | 117 | $6K | |
| 82787 | <1% | 104 | $6K | |
| 87184 | <1% | 684 | $6K | |
| 92595 | <1% | 1,360 | $6K | |
| 83655 | <1% | 291 | $6K | |
| 82533 | <1% | 760 | $6K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 134 | $6K |
| 85246 | <1% | 442 | $6K | |
| 82105 | <1% | 161 | $6K | |
| 86900 | <1% | 2,209 | $6K | |
| 76827 | <1% | 1,163 | $6K | |
| 84305 | <1% | 1,345 | $5K | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 2,926 | $5K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 4,473 | $5K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 1,295 | $5K |
| 71250 | <1% | 21 | $5K | |
| 84100 | <1% | 4,787 | $5K | |
| 87497 | <1% | 2,577 | $5K | |
| 43762 | <1% | 17 | $4K | |
| 82024 | <1% | 130 | $4K | |
| 73060 | <1% | 105 | $4K | |
| 82947 | <1% | 1,529 | $4K | |
| 76010 | <1% | 34 | $4K | |
| L1830 | Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf | <1% | 55 | $4K |
| 72070 | <1% | 102 | $4K | |
| 89230 | <1% | 44 | $4K | |
| B4087 | Gastrostomy/jejunostomy tube, standard, any material, any type, each | <1% | 129 | $4K |
| 76857 | <1% | 36 | $4K | |
| 94642 | <1% | 56 | $4K | |
| 87116 | <1% | 98 | $4K | |
| 77080 | <1% | 33 | $4K | |
| 00140 | <1% | 207 | $4K | |
| 24640 | <1% | 24 | $4K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 4,576 | $4K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,003 | $4K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 6,575 | $4K |
| 86255 | <1% | 629 | $4K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 57 | $3K |
| 85014 | <1% | 1,568 | $3K | |
| 85240 | <1% | 573 | $3K | |
| 73000 | <1% | 29 | $3K | |
| 36591 | <1% | 366 | $3K | |
| 86480 | <1% | 269 | $3K | |
| 84436 | <1% | 1,020 | $3K | |
| 82040 | <1% | 71 | $3K | |
| 83605 | <1% | 1,819 | $3K | |
| 86803 | <1% | 199 | $3K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $3K |
| 85045 | <1% | 4,858 | $3K | |
| 86160 | <1% | 1,487 | $3K | |
| 88313 | <1% | 390 | $3K | |
| J0697 | Injection, sterile cefuroxime sodium, per 750 mg | <1% | 106 | $3K |
| 93321 | <1% | 1,284 | $3K | |
| 86038 | <1% | 1,316 | $3K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,629 | $3K |
| 85730 | <1% | 2,623 | $2K | |
| 82627 | <1% | 1,030 | $2K | |
| 00126 | <1% | 144 | $2K | |
| 73660 | <1% | 45 | $2K | |
| 96411 | <1% | 347 | $2K | |
| 29125 | <1% | 107 | $2K | |
| 84030 | <1% | 581 | $2K | |
| 86901 | <1% | 2,208 | $2K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 363 | $2K |
| 92594 | <1% | 519 | $2K | |
| 74270 | <1% | 13 | $2K | |
| 92556 | <1% | 753 | $2K | |
| 81479 | Unlisted molecular pathology procedure | <1% | 160 | $2K |
| 87581 | <1% | 1,992 | $2K | |
| 87205 | <1% | 4,598 | $2K | |
| 80320 | <1% | 129 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 681 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,156 | $2K |
| 83519 | <1% | 56 | $2K | |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | <1% | 1,252 | $2K |
| 83001 | <1% | 1,072 | $2K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | <1% | 1,739 | $2K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 127 | $2K |
| 82375 | <1% | 1,454 | $2K | |
| 85018 | <1% | 1,753 | $2K | |
| 00635 | <1% | 123 | $2K | |
| 82977 | <1% | 2,044 | $2K | |
| 86665 | <1% | 178 | $2K | |
| P9041 | Infusion, albumin (human), 5%, 50 ml | <1% | 63 | $2K |
| 93356 | <1% | 954 | $2K | |
| 86360 | <1% | 1,325 | $2K | |
| 86359 | <1% | 1,375 | $1K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 2,442 | $1K |
| 92570 | <1% | 84 | $1K | |
| 80143 | <1% | 310 | $1K | |
| 82139 | <1% | 220 | $1K | |
| 84402 | <1% | 179 | $1K | |
| 86357 | <1% | 1,368 | $1K | |
| 87220 | <1% | 491 | $1K | |
| 84295 | <1% | 1,377 | $1K | |
| J2997 | Injection, alteplase recombinant, 1 mg | <1% | 38 | $1K |
| 86880 | <1% | 59 | $1K | |
| 92621 | <1% | 192 | $1K | |
| 77085 | <1% | 12 | $1K | |
| 81403 | <1% | 58 | $1K | |
| 69210 | <1% | 13 | $1K | |
| 84590 | <1% | 179 | $1K | |
| 87641 | <1% | 348 | $995.54 | |
| 84132 | <1% | 1,444 | $982.99 | |
| 86162 | <1% | 1,182 | $936.45 | |
| 84156 | <1% | 1,448 | $926.62 | |
| 80164 | <1% | 135 | $925.12 | |
| 86308 | <1% | 138 | $916.66 | |
| 93270 | <1% | 24 | $915.20 | |
| 83002 | <1% | 1,179 | $905.32 | |
| V5261 | Hearing aid, digital, binaural, bte | <1% | 15 | $862.88 |
| 90686 | <1% | 122 | $841.96 | |
| 88342 | <1% | 905 | $826.17 | |
| 77073 | <1% | 14 | $819.39 | |
| 70491 | <1% | 14 | $817.02 | |
| 83050 | <1% | 1,451 | $774.95 | |
| 82150 | <1% | 848 | $767.50 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 2,238 | $766.97 |
| 82248 | <1% | 847 | $730.99 | |
| 76830 | Ultrasound, transvaginal | <1% | 27 | $724.43 |
| 92602 | <1% | 15 | $682.66 | |
| 86341 | <1% | 83 | $669.88 | |
| 88230 | <1% | 69 | $668.19 | |
| 86376 | <1% | 1,750 | $644.52 | |
| 51600 | <1% | 70 | $635.66 | |
| 84550 | <1% | 956 | $634.51 | |
| 86648 | <1% | 691 | $604.79 | |
| 73502 | <1% | 12 | $601.39 | |
| 93971 | <1% | 27 | $600.86 | |
| 84480 | <1% | 721 | $582.90 | |
| 83919 | <1% | 28 | $580.47 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,178 | $561.19 |
| 29105 | <1% | 32 | $555.36 | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | <1% | 2,184 | $531.84 |
| 87449 | <1% | 12 | $531.00 | |
| 77074 | <1% | 12 | $528.59 | |
| 82435 | <1% | 1,269 | $499.55 | |
| V5160 | Dispensing fee, binaural | <1% | 12 | $454.26 |
| 87338 | <1% | 276 | $442.91 | |
| 00731 | <1% | 86 | $417.98 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 423 | $401.78 |
| 92583 | <1% | 12 | $395.19 | |
| 88184 | <1% | 66 | $362.41 | |
| 85576 | <1% | 12 | $350.72 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 13 | $339.32 |
| 86356 | <1% | 114 | $333.92 | |
| J9260 | Injection, methotrexate sodium, 50 mg | <1% | 281 | $326.78 |
| 80177 | <1% | 127 | $323.51 | |
| 80169 | <1% | 32 | $306.08 | |
| 86364 | <1% | 314 | $289.61 | |
| 84270 | <1% | 433 | $286.97 | |
| 82310 | <1% | 161 | $276.86 | |
| 82652 | <1% | 46 | $269.54 | |
| 86800 | <1% | 1,358 | $262.07 | |
| 87535 | <1% | 43 | $242.34 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 586 | $240.44 |
| 88341 | <1% | 181 | $235.72 | |
| 82270 | <1% | 100 | $235.19 | |
| 82379 | <1% | 70 | $229.61 | |
| 82820 | <1% | 1,011 | $222.67 | |
| 29515 | <1% | 30 | $218.67 | |
| 83918 | <1% | 13 | $213.66 | |
| 82010 | <1% | 164 | $213.64 | |
| 94726 | <1% | 126 | $212.16 | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 376 | $208.38 |
| 85379 | <1% | 338 | $200.99 | |
| 86774 | <1% | 712 | $173.65 | |
| 83525 | <1% | 246 | $159.32 | |
| 87181 | <1% | 358 | $155.79 | |
| 85397 | <1% | 246 | $154.07 | |
| 85384 | <1% | 394 | $149.88 | |
| 87206 | <1% | 189 | $149.86 | |
| 92611 | <1% | 393 | $136.51 | |
| 88185 | <1% | 15 | $121.99 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 6,557 | $116.90 |
| 80183 | <1% | 29 | $110.70 | |
| 84460 | <1% | 53 | $101.60 | |
| 87075 | <1% | 29 | $101.24 | |
| 86008 | <1% | 27 | $96.84 | |
| 87328 | <1% | 410 | $94.47 | |
| 84478 | <1% | 354 | $91.40 | |
| 86039 | <1% | 71 | $82.32 | |
| 87529 | <1% | 14 | $79.95 | |
| 00400 | <1% | 65 | $79.82 | |
| 87177 | <1% | 321 | $75.05 | |
| 94729 | <1% | 24 | $64.79 | |
| 86664 | <1% | 178 | $62.23 | |
| 86225 | <1% | 403 | $50.92 | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 295 | $50.20 |
| 86430 | <1% | 79 | $49.21 | |
| 00840 | <1% | 84 | $42.45 | |
| 87329 | <1% | 352 | $41.27 | |
| 88311 | <1% | 27 | $33.44 | |
| 86663 | <1% | 52 | $29.79 | |
| 31233 | <1% | 122 | $26.86 | |
| 85247 | <1% | 16 | $26.22 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 705 | $25.10 |
| 87210 | <1% | 49 | $25.10 | |
| J9250 | Methotrexate sodium, 5 mg | <1% | 360 | $25.09 |
| 84481 | <1% | 39 | $23.73 | |
| 0011A | <1% | 12 | $16.94 | |
| 84630 | <1% | 84 | $15.07 | |
| 86644 | <1% | 46 | $14.35 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 67 | $14.15 |
| 85613 | <1% | 27 | $13.45 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 1,505 | $12.94 |
| 84450 | <1% | 13 | $10.24 | |
| 82438 | <1% | 57 | $7.06 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 821 | $0.00 |
| 82945 | 0% | 13 | $0.00 | |
| 88307 | 0% | 16 | $0.00 | |
| J3535 | Drug administered through a metered dose inhaler | 0% | 1,886 | $0.00 |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 0% | 39 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 219 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 145 | $0.00 |
| 81268 | 0% | 27 | $0.00 | |
| 82077 | 0% | 161 | $0.00 | |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 19 | $0.00 |
| 86777 | 0% | 15 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 32 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 127 | $0.00 |
| 84410 | 0% | 89 | $0.00 | |
| 72158 | 0% | 13 | $0.00 | |
| 82390 | 0% | 13 | $0.00 | |
| 94761 | 0% | 15 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 14 | $0.00 |
| 86778 | 0% | 15 | $0.00 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 0% | 45 | $0.00 |
| 81374 | 0% | 12 | $0.00 | |
| 94760 | 0% | 18 | $0.00 | |
| 84157 | 0% | 13 | $0.00 | |
| 80179 | 0% | 239 | $0.00 | |
| 81267 | 0% | 40 | $0.00 | |
| J7070 | Infusion, d5w, 1000 cc | 0% | 410 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 121 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 134 | $0.00 |
| 81406 | 0% | 30 | $0.00 | |
| 85347 | 0% | 39 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 210 | $0.00 |
| 76942 | 0% | 45 | $0.00 | |
| 87102 | 0% | 45 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 45 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 64 | $0.00 |
| 97129 | 0% | 62 | $0.00 | |
| 84145 | 0% | 43 | $0.00 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 22 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 59 | $0.00 |
| 81405 | 0% | 13 | $0.00 | |
| 94681 | 0% | 15 | $0.00 | |
| J3262 | Injection, tocilizumab, 1 mg | 0% | 17 | $0.00 |
| 81404 | 0% | 19 | $0.00 | |
| 86200 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHULHOF, KRISTY (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Pediatric Physician Services, INC. | St Petersburg, FL | $43.40M |
| West Coast Neonatology, INC. | St Petersburg, FL | $18.81M |
| All Children's Perinatology Specialists | St Petersburg, FL | $1.77M |
| Johns Hopkins All Children's Hospital, INC. | St Petersburg, FL | $761K |
| All Children's Ob/Gyn Specialists | St Petersburg, FL | $413K |
| Johns Hopkins All Children's Hospital, INC. | St Petersburg, FL | $337K |
| Johns Hopkins All Children's Hospital, INC. | St Petersburg, FL | $165K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.